Sign inCreate account

Report workspace tools

NCT02170779COMPLETEDanonymous

Developing and Testing a Comprehensive MS Spasticity Management Program

Sponsor

Source record

VA Office of Research and Development

Phase

Source record

PHASE2

Modality

AI-normalized

behavioral intervention

Target

AI-normalized

Spasticity: Take Control, Usual care

Indication / condition

AI-normalized

Multiple Sclerosis

Intervention

Source record

Spasticity: Take Control, Usual care

Source & freshness

Source record

NCT ID

NCT02170779

Original source

ClinicalTrials.gov

Source last updated

Mar 28, 2017

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT02170779

Title

Developing and Testing a Comprehensive MS Spasticity Management Program

Sponsor

VA Office of Research and Development

Status

COMPLETED

Phase

PHASE2

Condition raw

Multiple Sclerosis

Condition normalized

Multiple Sclerosis

Modality raw

multiple sclerosis

Modality normalized

behavioral intervention

Target raw

Spasticity: Take Control, Usual care

Target normalized

Spasticity: Take Control, Usual care

Interventions

Spasticity: Take Control, Usual care

Public preview

Source record

Developing and Testing a Comprehensive MS Spasticity Management Program is a PHASE2 clinical asset sponsored by VA Office of Research and Development in Multiple Sclerosis, Spasticity. SEO and diligence focus: Spasticity: Take Control, Usual care, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Developing and Testing a Comprehensive MS Spasticity Management Program

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT02170779

Status

COMPLETED

Phase

PHASE2

Sponsor

VA Office of Research and Development

Executive brief

Investment-Ready Snapshot

Developing and Testing a Comprehensive MS Spasticity Management Program is a PHASE2 clinical asset sponsored by VA Office of Research and Development in Multiple Sclerosis, Spasticity. SEO and diligence focus: Spasticity: Take Control, Usual care, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedMar 28, 2017
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT02170779

Indication

Multiple Sclerosis

Modality

behavioral intervention

Target

Spasticity: Take Control, Usual care

Intervention

Spasticity: Take Control, Usual care

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.